Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Scott A. Armstrong, M.D.,Ph.D.

Co-Author

This page shows the publications co-authored by Scott Armstrong and Matthew Hemming.
Connection Strength

1.080
  1. HAND1 and BARX1 Act as Transcriptional and Anatomic Determinants of Malignancy in Gastrointestinal Stromal Tumor. Clin Cancer Res. 2021 Mar 15; 27(6):1706-1719.
    View in: PubMed
    Score: 0.239
  2. Oncogenic Gene-Expression Programs in Leiomyosarcoma and Characterization of Conventional, Inflammatory, and Uterogenic Subtypes. Mol Cancer Res. 2020 09; 18(9):1302-1314.
    View in: PubMed
    Score: 0.229
  3. Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and Are Targetable by BET Bromodomain Inhibition. Cancer Res. 2019 03 01; 79(5):994-1009.
    View in: PubMed
    Score: 0.208
  4. Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma. Elife. 2018 11 15; 7.
    View in: PubMed
    Score: 0.205
  5. Gastrointestinal stromal tumor enhancers support a transcription factor network predictive of clinical outcome. Proc Natl Acad Sci U S A. 2018 06 19; 115(25):E5746-E5755.
    View in: PubMed
    Score: 0.199
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.